ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of ...

Identifying regions with expertise can improve how patients access those best at managing the disease, Richard Soucier says.

A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.

Premature heart disease in men and women in this population stands out in a way that it doesn’t in other ethnic groups.

The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ...

The US Food and Drug Administration has approved the Selution SLR sirolimus-eluting balloon for the treatment of coronary ...

Leaders call for removal of this outdated metric, which they say has no bearing over ongoing interventional cardiologist ...

TCTMD's Todd Neale spoke with Warraich about the ADVOCATE program, which has its sights set on heart failure first.

Seamlessly merging the AHA’s new CV risk calculators into the country’s largest electronic health record system marks a big win.

Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.

The findings align with the PROLONG registry and bolster evidence for limiting the duration of antithrombotic therapy.

Lead author Amar Rai, MBBS (University of Pennsylvania, Philadelphia, and Imperial College London, England), said that as a clinician working with patients who have high bleeding risks in general, he ...